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INTRODUCTION
The oral cavity and nasopharynx of children with
unrepaired cleft lip and palate are recognized to be at
an increased risk of colonization by bacterial
pathogens. Significant interest has been generated
among clinicians about the role of infections in the
development of complications following cleft surgery
in these patients. A causal relationship has long been
established between infection and failure of surgical
repair1-3.
Several publications on children with clefts have
identified oral flora of microorganisms pre-operatively
and the association of post-operative complications
with pathogenic organisms found in the perioperative
period4-7. These complications can result in systemic
infection for the child, secondary heamorrhage, wound
dehiscence, palatal fistulae with resultant prolonged
hospital stay. Subsequent morbidities may include poor
speech, impaired appearance and impaired facial
development8. Hupkens et al.9 reported a strong
association between preoperative cultures especially of
Group A Streptococcus and Staphylococcus aureus
and postoperative palatal dehiscence. Previous studies
have also confirmed that patients with orofacial clefts
are at increased risk for the development of caries
and periodontal diseases compared to noncleft
children10,11.
Primary closure of cleft lip and palate is classified as a
clean contaminated operation, and wound infection is
a recognized risk. The risks are associated with the
duration of operation especially with primary cleft
operations often requiring 1–2 h of operating time.12
The consequences of surgical wound infection after
repair of cleft lip or palate can be devastating in both
the short and the long term. A major wound infection
after primary repair of a cleft anomaly is likely to
require a further admission for a secondary
intervention; however, final outcomes such as speech
and growth may also be compromised.
Antibiotics are likely to reduce the incidence of wound
infection and complications, but this has never been
clearly shown in randomized clinical trials in repair of
clefts8. Despite the beneficial effects of antibiotics, its
widespread use may result in increasing rates of
antibiotic resistance in addition to increased cost of
care especially for families making out of pocket
payment for their children’s care13. This can constitute
additional burden on such parents. Unfortunately, there
is currently no global, regional or national guidelines
for the rational use of antibiotic prophylaxis in repair
of  orofacial clefts.
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Clefts of  the primary and secondary palate represent one of  the commonest
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as well as the current evidences for the use of perioperative antibiotic therapy
in orofacial cleft surgery and concludes with a need for a large multicenter
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This review seeks to evaluate the arguments for or
against the use of peri-operative antibiotics therapy
for CLP surgeries based on available literature and
draw conclusions that could guide rational choice by
surgeons and other practitioners.
Bacteremia in Cleft and Oral Surgeries
Several studies have documented significant bacteremia
following cleft lip and palate and intraoral surgeries14-
19. These procedures were diverse and ranged from
cleft lip and palate (CLP) surgeries, tooth extraction
and removal of osteosynthesis plates, third molar
surgeries and some maxillofacial procedures. Previous
assertions have been that bacteremia associated with
oral surgeries in healthy individuals is transient without
significant sequel20,21. However, a recent study has
documented bacteremia following cleft lip and palate
surgeries persisting for up to 15 minutes in 53% of
the patients19. The bacteremia in this group of patients
was also higher than those for oral procedures such as
orthodontic procedures and root scaling. The
implication of the finding is that cleft-related surgery
could be harmful in patients at risk, especially those
with associated cardiac anomalies. Factors that were
associated with development of bacteremia in patients
with CLP anomaly included age less than 62.3 months
and the male gender (59.4%), although these factors
were not statistically significant. On the relationship
between bacteremia and the specific type of  surgery,
the authors found that the prevalence of bacteremia
in cleft lip surgery was 40.9%, whereas the incidence
in cleft palate surgery was 33.3%. A prevalence of
50% was recorded for alveoloplasty. No reason was
proposed for these differences. It was also found that
bacteremia associated with CLP surgeries in the study
was polymicrobial, similar to findings from several
other studies that reported polymicrobial bacteraemia
following other dental procedures14,16,18,22. These
organisms in the oral cavity can gain access into the
blood stream during these procedures23-25.
Based on their findings, Adeyemo et al19 advocated
for the need for prophylactic antibiotic therapy for
CLP because of the patients with associated congenital
heart defects and the risks for bacteria endocarditis in
this group of  patients.
Bacteriology of Oral Flora
The oral cavity, which remains sterile throughout
prenatal development, becomes a diverse ecosystem
colonized by several microorganisms during the first
few hours after delivery. The skin and mucus
membranes of neonates are colonized by microbiota
as a result of contact with the external environment. A
significant part of the oral microbiota in the early
neonatal period originates from the mother and is
transient population of microorganisms consisting of
intestinal bacteria26. The spectrum of organisms at this
stage depends mainly on factors such as the gestational
age of  the baby, the mode of  delivery, type of  feeding
and the length of hospital stay26-32.
The early oral microbiota occurring within several
hours following delivery is composed of viridans
streptococci and Streptococcus salivarius (S. salivarius),
which are commensals permanently colonizing the oral
cavity28. Along with other bacteria, they participate in
the formation of  a “colonization cascade” that
determines future indigenous microbiota 28,29,33.
Congenital orofacial malformation affects the structure
and functions of  the oral cavity, thereby significantly
modifying its characteristics 9. Both abnormal
morphology and improper function of  the oral cavity
in newborns with cleft palate create a different
environment from that of  healthy neonates. Therefore,
these abnormalities may affect oral microbiota34.
The oral cavity is replete with diverse strains of
microorganisms. Organisms that are commonly found
include Staphylococcus aureus (SA) and b-hemolytic
streptococci (bHS), when compared with the normal
population19,34,35. More than 500 different bacteria
strains have been identified in the oral cavity36. The
oral microbial community is normally in equilibrium,
but a compromise of the ecological balance can occur
and result in surgical site infection.  A list of the most
important bacteria commonly isolated from the oral
cavity is presented in Table 137.
Antibiotic Therapy in Cleft Surgery
Operations in the aero digestive tract are frequently
considered as clean contaminated and the incidence
of surgical site infections (SSI) is about 10 to 15%
which represents a significant health burden38. By
definition, a SSI is an infection that develops within 30
days after an operation or within 1 year of an implant
being placed, where the infection appears to be related
to the surgery39. Perioperative antibiotics are generally
used in surgery to prevent SSI. In contrast to
therapeutically used antibiotics, the perioperative
treatment aims to reduce contamination of the bacterial
flora in the specific surgical area. The basic purpose
of antibiotic prophylaxis is, therefore, to provide an
adequate drug level in the tissues before, during, and
for the shortest possible time after the procedure38.
Prophylactic antibiotic treatment is defined as the use
of antibiotics before, during, or after a diagnostic,
therapeutic, or surgical procedure to prevent infectious
complications. It has been estimated that approximately
half of SSIs are preventable by application of
evidence-based strategies40.
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The Scottish Intercollegiate GL Network (SIGN)
guideline “Antibiotic prophylaxis in surgery” defines
two regimens; the short-term prophylaxis administered
any time before or after surgery for up to 24 h after
the surgical intervention and long-term antibiotic
prophylaxis that is continued for longer than 24 h. In
contrast, therapeutic antibiotic treatment is used to
reduce the growth or reproduction of bacteria,
including eradication therapy. Antimicrobial therapy is
then prescribed to clear infection by an organism or





Porphyromonas P. gingivalis, P. endodontalis, P. catoniae
Prevotella P. oralis, P. oris, P. buccae, P. corporis, P. denticola, P. loescheii,
P. intermedia, P. nigrescens, P. melaninogenica,
Fusobacterium F. nucleatum spp. nucleatum, spp. vincentii, spp. polymorphum
Mitsuokella M. dentalis
Selenomonas S. sputigena, S. noxia
Campylobacter C. sputorum, C. rectus, C. curvus
Treponema T. denticola, T. vincentii, T. socranski
Bacteroides B. forsythus
Gram-positive rods
Eubacterium E. alactolyticum, E. lentum, E. yurii
Propionibacterium P. acnes, P. propionicus, P. jensenii, P. granulosum, P. avidum
Lactobacillus L. catenaforme, L. crispatus, L. oris, L. uli, L. grasseri
Actinomyces A. israelii, A. odontolyticus, A. meyeri
Arachnia A. propionica
Gram-negative cocci
Veillonella V. parvula, V. alcalescens
Gram-positive cocci








Haemophilus H. aphrophilus H. influenzae, H. parainfluenzae, H.
paraphrophilus, H. segnis
Gram-positive rods
Corynebacteriu C. xerosis, C. matruchotii
Actinomyces A. naeslundii, A. viscosus
Rothia R. dentocariosa
Lactobacillus L. acidophilus, L. brevis, L. buchneri, L. casei, L. salivarius, L.
fermentum
Gram-negative cocci
Neisseria N. flavescens, N. mucosa, N. sicca, N. subflava
Branhamella B. catarrhalis
Gram-positive cocci
Streptococcus S. mutans, S. sanguis, S. salivarius, S. sobrinus, S. rattus, S. downei,
S. mitis, S. milleri, S. oralis, S. intermedius, S. constellatus
Staphylococcus S. aureus, S. epidermidis
Enterococcus E. faecalis, E. faecium
Table 1: Bacteria commonly isolated from the oral cavity
Based on Mouton and Robert (2)
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Despite the obvious benefits of antibiotics, their
excessive and indiscriminate use may not only be
uneconomical but also result in the risk for developing
multiple drug resistance in bacteria which is claimed
to be a major cause of the failure of therapy in many
human infections42. Therefore, appropriate use of
antibiotics is seen as a national health priority to prevent
the morbidity of infections and the development of
resistant organisms40.
The consequences of surgical wound infection after
repair of cleft lip or palate can be devastating in both
the short and the long term. A major wound infection
after primary repair of a cleft is likely to require a
further admission for a secondary intervention;
however, final outcomes such as speech and growth
may also be compromised. Antibiotics are likely to
reduce the incidence of wound infection and
complications8 but there are limited randomized clinical
trials on the use of perioperative antibiotics in repair
of  clefts.
A survey among surgeons doing primary cleft surgery
in the UK and Ireland showed a lack of consensus
and considerable disparity among cleft centres in the
UK about antibiotic prophylaxis for primary cleft
surgery. Most of  these cleft surgeons use an antibiotic
for prophylaxis during repair of  a cleft lip, some
surgeons continue this for 5 days although there is no
supporting evidence of  additional benefit. Unusually,
a slightly higher proportion of surgeons would not
use any form of  antibiotic prophylaxis for repair of  a
cleft palate than for isolated repair of  a cleft lip, and
although nearly half would not use any antibiotic
prophylaxis afterwards, a third would continue to give
it for 5 days8.
A similar survey among members of  the American
Cleft Palate-Craniofacial Association found out that
eighty-five percent of the surgeons administered
prophylactic antibiotics, including 26% who used a
single preoperative dose. A further 23% gave 24 hours
of postoperative therapy; 12% used 25 to 72 hours,
16% used 4 to 5 days, and 12% used 6 to 10 days.
Five percent of surgeons administered penicillin, 64%
administered a first-generation cephalosporin, 13%
administered ampicillin/sulbactam, and 8% gave
clindamycin. The authors also retrospectively reviewed
311 patients out of which 173 received antibiotics and
138 did not. They found out that delayed healing and
fistula rates did not differ between the groups: 16.8%
versus 15.2% (p = 0.71) and 2.9% versus 1.4% (p =
0.47), respectively43.
A prospective, double blind randomized placebo
controlled clinical trial conducted in India reported a
higher incidence of early complications (13.8%) among
the patients in the placebo group compared to 8.7%
(p=0.175) in the antibiotic group which consisted of
a five-day course of postoperative oral amoxicillin
(50mg/kg/day). The study also found a higher
incidence of fistulae (17.1%) in the placebo group
compared to the antibiotic group (10.7%) (p= 0.085).
These differences in the early and late complication
rates were however not statistically significant44. A large
retrospective series comprising 3,108 patients from
India found no difference in the wound infection rates
between the group which had postoperative antibiotics
and the group which did not45.
CONCLUSION
Although the efficacy of perioperative prophylactic
antibiotics in preventing postoperative wound
infections after clean-contaminated surgery where the
aerodigestive tract is violated has been clearly
established in clinical trials46-48, only scarce evidence exists
for its use in cleft lip, alveolus and palate surgery.
Primary efficiency endpoint was occurrence of
postoperative fistulae. Here, antibiotic prophylaxis as
single shot or 5-day regime failed to show reduction
of statistical significance43,44. In addition, incidence of
wound infections was low even without the use of
postoperative antibiotics45. Up to date, the use of
antibiotic prophylaxis in cleft lip and palate surgeries
have not been substantiated. A large multicenter
randomized clinical trial with specific selection criteria
is recommended to further elucidate the benefit or
otherwise of prophylactic and therapeutic antibiotic
therapy in the surgical management of orofacial cleft.
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